Literature DB >> 18704207

Helicobacter pylori--the latest in diagnosis and treatment.

Björn Stenström1, Aruni Mendis, Barry Marshall.   

Abstract

BACKGROUND: European and North American guidelines on the management of Helicobacter pylori infection were updated in 2007. New diagnostic methods have been introduced and in Australia, the recommended therapy choices in cases of penicillin allergy and for second line treatment are only accessible through the Therapeutic Goods Administration Special Access Scheme.
OBJECTIVE: The article aims to update general practitioners on recommendations for testing and treating H. pylori infection, practical aspects of diagnostic methods, proof of cure testing to prove eradication, and the management of eradication failure and recurrent infection. DISCUSSION: Urea breath tests are the best way to diagnose current H. pylori infection. Serology should primarily be used when UBTs may be false negative, eg. current bleeding ulcer or H. pylori suppressing drugs. For children who cannot use UBTs, stool antigen tests may be useful. In case of eradication failure with standard clarithromycin based therapy, bismuth based quadruple therapy is the favoured second line therapy. Preparing the patient for possible side effects is important as poor compliance and antibiotic resistance are the main reasons for eradication failure.

Entities:  

Mesh:

Year:  2008        PMID: 18704207

Source DB:  PubMed          Journal:  Aust Fam Physician        ISSN: 0300-8495


  15 in total

1.  Helicobacter pylori infection and the risk of acute coronary syndrome: a nationwide retrospective cohort study.

Authors:  C-Y Lai; T-Y Yang; C-L Lin; C-H Kao
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2014-07-26       Impact factor: 3.267

2.  In silico quest for putative drug targets in Helicobacter pylori HPAG1: molecular modeling of candidate enzymes from lipopolysaccharide biosynthesis pathway.

Authors:  Munmun Sarkar; Lakshmi Maganti; Nanda Ghoshal; Chitra Dutta
Journal:  J Mol Model       Date:  2011-08-18       Impact factor: 1.810

3.  Changing Patterns of the Prevalence of Helicobacter Pylori Among Patients at a Corporate Hospital in Ghana.

Authors:  R Darko; A E Yawson; V Osei; J Owusu-Ansah; S Aluze-Ele
Journal:  Ghana Med J       Date:  2015-09

Review 4.  Diagnosis and management of nonvariceal upper gastrointestinal bleeding.

Authors:  Marc Bardou; Dalila Benhaberou-Brun; Isabelle Le Ray; Alan N Barkun
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2012-01-10       Impact factor: 46.802

5.  Epidemiology of Helicobacter pylori in Australia: a scoping review.

Authors:  Jillian Congedi; Craig Williams; Katherine L Baldock
Journal:  PeerJ       Date:  2022-05-31       Impact factor: 3.061

Review 6.  A review of Helicobacter pylori diagnosis, treatment, and methods to detect eradication.

Authors:  Elvira Garza-González; Guillermo Ignacio Perez-Perez; Héctor Jesús Maldonado-Garza; Francisco Javier Bosques-Padilla
Journal:  World J Gastroenterol       Date:  2014-02-14       Impact factor: 5.742

7.  Diagnostic yield of capsule endoscopy in the setting of iron deficiency anemia without evidence of gastrointestinal bleeding.

Authors:  Jessica Tong; Sigrid Svarta; George Ou; Ricky Kwok; Joanna Law; Robert Enns
Journal:  Can J Gastroenterol       Date:  2012-10       Impact factor: 3.522

Review 8.  Brain-gut axis in the pathogenesis of Helicobacter pylori infection.

Authors:  Jacek Budzyński; Maria Kłopocka
Journal:  World J Gastroenterol       Date:  2014-05-14       Impact factor: 5.742

9.  A 2-week Nitazoxanide-based quadruple treatment as a rescue therapy for Helicobacter pylori eradication: A single center experience.

Authors:  Sherief Abd-Elsalam; Abdelrahman Kobtan; Ferial El-Kalla; Walaa Elkhalawany; Sally El Nawasany; Sabry Abou Saif; Mohamed Yousef; Lobna Abo Ali; Samah Soliman; Loai Mansour; Eslam Habba; Hanan Soliman; Fatma Rizk; Mona Ah Shehata
Journal:  Medicine (Baltimore)       Date:  2016-06       Impact factor: 1.889

Review 10.  Cydonia oblonga M., A Medicinal Plant Rich in Phytonutrients for Pharmaceuticals.

Authors:  Muhammad U Ashraf; Gulzar Muhammad; Muhammad A Hussain; Syed N A Bukhari
Journal:  Front Pharmacol       Date:  2016-06-21       Impact factor: 5.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.